Gemma Jones

Gemma Jones is a Translational Pathology Scientific Director at AstraZeneca, where they have held multiple leadership roles, including Early Stage Translational Pathology Group Lead. Previously, they worked as a Translational Scientist at Fahy Gurteen UK Limited from 2013 to 2015. Gemma earned a Doctor of Philosophy (Ph.D.) in Cell Biology and Cell Therapy from Imperial College London and holds a Bachelor's Degree in Biological Sciences as well as a Master's Degree in Reproductive and Developmental Biology from the same institution.